Cargando…

Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents

BACKGROUND: Sofosbuvir is the keystone of direct antiviral agents for the chronic hepatitis C (CHC). The safety of sofosbuvir in patients with stage 4–5 chronic kidney disease (CKD) needs further observation in real world. CASE PRESENTATION: Thirty-three patients with stage 5 CKD and hepatitis C vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Taotao, Wang, Jiuping, Li, Juan, Fu, Shan, Chen, Yi, Hu, Chunhua, Zhang, Rou, Tian, Zhen, Zhao, Fahui, Dong, Jun, Liu, Jinfeng, Yang, Yuan, Chen, Tianyan, Zhao, Yingren, He, Yingli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588848/ https://www.ncbi.nlm.nih.gov/pubmed/31226947 http://dx.doi.org/10.1186/s12879-019-4117-x

Ejemplares similares

High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
por: Wang, Jing, et al.
Publicado: (2021)

Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B
por: Li, Juan, et al.
Publicado: (2021)

Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
por: Yao, Naijuan, et al.
Publicado: (2022)

Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China
por: Chen, Tianyan, et al.
Publicado: (2018)

Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression
por: Zhang, Yu, et al.
Publicado: (2016)

An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother
por: Liu, Jinfeng, et al.
Publicado: (2015)

2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus
por: Liu, Jinfeng, et al.
Publicado: (2020)

The Clinical Characteristics and Outcomes of Hemorrhagic Fever With Renal Syndrome in Pregnancy
por: Ren, Danfeng, et al.
Publicado: (2022)

Efficacy of Antiviral Treatment in Liver Biopsy-Proven Immune-Tolerant Chronic Hepatitis B Patients: A Retrospective Cohort Study
por: Liu, Na, et al.
Publicado: (2021)

Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis
por: Wu, Yuchao, et al.
Publicado: (2020)

Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy
por: Zhang, Ze, et al.
Publicado: (2023)

Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma
por: Zhang, XiaoGang, et al.
Publicado: (2019)

The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China
por: Yang, Yuan, et al.
Publicado: (2018)

Mechanisms of fibrosis in acute liver failure
por: He, Yingli, et al.
Publicado: (2015)

Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease
por: Chen, Hongmei, et al.
Publicado: (2022)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
por: Zhang, Mengmeng, et al.
Publicado: (2021)

Recurrent Hyperkalemia During General Anesthesia in a Dog
por: Tong, Carissa W., et al.
Publicado: (2020)

Psychological Stress Exerts Effects on Pathogenesis of Hepatitis B via Type-1/Type-2 Cytokines Shift toward Type-2 Cytokine Response
por: He, YingLi, et al.
Publicado: (2014)

Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
por: Sarnowski, Alexander, et al.
Publicado: (2022)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Hyperkalemia and Rhabdomyolyssis
por: Yasri, Sora, et al.
Publicado: (2015)

New Antiviral Agents for Hepatitis C
por: Pawlotsky, Jean-Michel
Publicado: (2012)

Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
por: Kim, Gheun-Ho
Publicado: (2019)

New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
por: Esposito, Pasquale, et al.
Publicado: (2020)

Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
por: Jo, Sang Min
Publicado: (2023)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
por: Yang, Chen-Ta, et al.
Publicado: (2018)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
por: Khanagavi, Jagadish, et al.
Publicado: (2014)

Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes
por: Alrashidi, Tahani Nasser, et al.
Publicado: (2020)

Autophagy in inflammation: the p38α MAPK-ULK1 axis
por: She, Hua, et al.
Publicado: (2018)

An unusual manifestation of hyperkalemia
por: Belkouch, Ahmed, et al.
Publicado: (2014)

Hyperkalemia and severe rhabdomyolysis
por: Mugmon, Marc
Publicado: (2011)

Hyperkalemia in heart failure
por: Sidhu, Kiran, et al.
Publicado: (2020)

Acute hyperkalemia in adults
por: Emektar, Emine
Publicado: (2023)

Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia
por: Cook, Erin E., et al.
Publicado: (2021)

Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury
por: Nishimura, Yoshito
Publicado: (2022)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Life-threatening Hyperkalemia Associated with Axitinib Treatment in Patients with Recurrent Renal Carcinoma
por: Godo, Shigeo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5qhkos4aq9ktubljooj8f71q82